Similar articles

• Hepatitis C in organ donors and heart transplant recipients.

  Taylor RM, Fontana RJ. Taylor RM, et al. JAMA. 2007 Feb 21;297(7):696; author reply 696-7. doi: 10.1001/jama.297.7.696-a. JAMA. 2007. PMID: 17312284 No abstract available.
• Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.

  Pereira BJ, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, Wilber JC, Levey AS. Pereira BJ, et al. N Engl J Med. 1992 Sep 24;327(13):910-5. doi: 10.1056/NEJM199209243271302. N Engl J Med. 1992. PMID: 1325035
• Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.

  Haji SA, Starling RC, Avery RK, Mawhorter S, Tuzcu EM, Schoenhagen P, Cook DJ, Ratliff NB, McCarthy PM, Young JB, Yamani MH. Haji SA, et al. J Heart Lung Transplant. 2004 Mar;23(3):277-83. doi: 10.1016/S1053-2498(03)00148-7. J Heart Lung Transplant. 2004. PMID: 15019636
• Hepatitis C virus and nonliver solid organ transplantation.

  Carbone M, Mutimer D, Neuberger J. Carbone M, et al. Transplantation. 2013 Mar 27;95(6):779-86. doi: 10.1097/TP.0b013e318273fec4. Transplantation. 2013. PMID: 23172130 Review.
• Should we be using kidneys from hepatitis C virus-infected donors?

  Domínguez-Gil B, Andrés A, Campistol JM, Morales JM. Domínguez-Gil B, et al. Curr Opin Nephrol Hypertens. 2011 Nov;20(6):599-604. doi: 10.1097/MNH.0b013e32834bba37. Curr Opin Nephrol Hypertens. 2011. PMID: 21946162 Review.